title: Letter: should HCV cirrhotics with high bilirubin or Gilbert's syndrome be excluded from paritaprevir, ombitasvir, or dasabuvir? Authors' reply.
authors.affiliation: Division of Gastroenterology/Hepatology, University of Pennsylvania, Philadelphia, PA, USA.
authors.forename: D
authors.initials: D
authors.lastname: Banerjee
authors.affiliation: Division of Gastroenterology/Hepatology, University of Pennsylvania, Philadelphia, PA, USA. rajender.reddy@uphs.upenn.edu.
authors.forename: K R
authors.initials: KR
authors.lastname: Reddy
mesh_terms: D001663:Bilirubin; D005878:Gilbert Disease; D019698:Hepatitis C, Chronic / Q000188:drug therapy; D006801:Humans; D008103:Liver Cirrhosis / Q000188:drug therapy; D012254:Ribavirin / Q000627:therapeutic use
chemical_list: D012254:Ribavirin; D001663:Bilirubin